

RETATRUTIDE 10 MG INJECTION
Drug Class: Multi-Agonist Peptide
Composition:
- Active Substance: Retatrutide
- Concentration: 10 mg/vial
Presentation: Lyophilized peptide in 2 mL Vial
Storage: Store lyophilized powder in a cool, dry place. Refrigerate after reconstitution.
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
Retatrutide 10 mg is a next-generation multi-agonist peptide designed to support metabolic regulation, weight loss, and glycemic control. Developed by Peptide Hubs, this compound has gained attention in scientific research due to its powerful effects on GLP-1, GIP, and glucagon receptors. The triple receptor action makes it an exciting candidate for advanced studies on obesity, insulin sensitivity, and energy homeostasis.
Retatrutide is a synthetic peptide under clinical investigation for its potent effects on appetite suppression, fat loss, and insulin resistance. Unlike conventional GLP-1 analogs, Retatrutide simultaneously activates GLP-1R, GIPR, and GCGR, potentially offering superior results in weight and metabolic management. It is intended for research purposes only and is not approved for human consumption.
Through its unique triple agonist mechanism, Retatrutide works on several hormonal pathways to regulate glucose metabolism and energy balance. Researchers have observed improvements in HbA1c, body weight, and lipid markers in animal models and early clinical trials. As a result, it is gaining traction among scientists exploring advanced treatments for type 2 diabetes and obesity-related conditions.
This product comes lyophilized in a 10 mg vial and is typically reconstituted with bacteriostatic water before use in research protocols. Common research studies administer Retatrutide via subcutaneous injection. For specific research protocols and peptide compatibility, many researchers also stack it with GHK-CU 10 mg or Semaglutide 5 mg.
When studying fat loss and metabolic enhancement, researchers often combine Retatrutide with synergistic compounds. A popular research pairing includes Cagrilintide for appetite regulation and Tesofensine for enhanced CNS-mediated fat mobilization. You can also explore the combination with AOD-9604 for a broader view of adipose targeting.
If you're sourcing research-grade peptides from a trusted supplier, this high-quality Retatrutide peptide by Peptide Hubs offers verified purity and performance. Known for their lab-tested catalog and rapid U.S. shipping, Peptide Hubs has earned recognition across the research peptide community.
Retatrutide is a triple agonist peptide being studied for its effects on weight loss, insulin sensitivity, and metabolic disorders like type 2 diabetes.
No, Retatrutide is for research purposes only and is not approved by the FDA for human consumption or therapeutic use.
Store the lyophilized vial in a cool, dry place. After reconstitution, refrigerate and use within the stability window advised for peptides.
Yes, researchers often combine it with peptides like Cagrilintide or Semaglutide to enhance metabolic and fat-loss outcomes in study models.
Please log in to write Retatrutide 10 mg review.
RETATRUTIDE 10 MG INJECTION
Drug Class: Triple Agonist (GLP-1 + GIP + Glucagon Receptor Agonist)
Composition:
- Active Substance: Retatrutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report